T2 Biosystems, Inc.
TTOO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,117 | -$8,963 | -$13,534 | -$10,340 |
| Dep. & Amort. | $59 | $62 | $64 | $74 |
| Deferred Tax | $0 | $0 | $0 | -$923 |
| Stock-Based Comp. | $216 | $196 | $1,595 | $728 |
| Change in WC | $968 | $93 | -$593 | -$523 |
| Other Non-Cash | $2,622 | -$629 | $785 | $1,568 |
| Operating Cash Flow | -$6,252 | -$9,241 | -$11,683 | -$9,416 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$26 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$26 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,089 | $7,269 | $2,203 | $795 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $10 | -$1 | $17 |
| Financing Cash Flow | $4,089 | $7,279 | $2,202 | $812 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,163 | -$1,962 | -$9,481 | -$8,630 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,246 | $6,208 | $15,689 | $24,319 |
| End Cash | $2,634 | $4,246 | $6,208 | $15,689 |
| Free Cash Flow | -$6,252 | -$9,241 | -$11,683 | -$9,442 |